AzTrials
AzTrials

Posterior CrossbiteExpansionNCT07500194

Quad Helix vs RME for Posterior Cross-bite in Egyptian Children

A study testing Quad Helix(QH) Appliance and Rapid Maxillary Expanders in people with Posterior Crossbite and Maxillary Expansion, run by Al-Azhar University at 1 site in Egypt.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

This randomized clinical trial aims to evaluate and compare the effectiveness of the Quad Helix (QH) appliance versus Rapid Maxillary Expanders (RME) in treating posterior cross-bite in Egyptian children during the mixed dentition stage. Read more about this study

Who is it for?
Ages 9 to 12 years
What is being tested?
Quad Helix(QH) Appliance and Rapid Maxillary Expanders
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
1 siteEgypt
Study dates
30 Mar 2026to 31 Mar 2028
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 9 to 12 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Children aged 9-12 years in the mixed dentition stage
  • Presence of posterior cross-bite due to transverse maxillary deficiency
  • No previous history of orthodontic treatment
  • Good oral hygiene and cooperative behavior
  • No significant antero-posterior or vertical skeletal discrepancies

Who cannot join

  • Patient with craniofacial anomalies
  • Presence of systemic diseases or syndromes affecting bone metabolism
  • Extensive dental caries or untreated periodontal disease
  • History of trauma or surgery affecting the maxilla or mandible

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Moustafa Galal Borham Moustafa Saad, Bachelor of dental Science contact

+201026896894 ext. +201155874709

moustafagalal.1.209@azhar.edu.eg

Egypt1 site
  • Faculty of Dental medicine (boys) ,Cairo,Al-Azhar University

    Cairo, Cairo Governorate, 00000

    Moustafa G Saad, BDS, +201026896894 ext. +201155874709, moustafagalal.1.209@azhar.edu.eg

Other trials in Egypt

About this study

Official title: Quad Helix Versus Rapid Maxillary Expanders in the Treatment of Posterior Cross-bite During Mixed Dentition in a Sample of Egyptian Children: A Randomized Clinical Study.

This randomized clinical trial aims to evaluate and compare the effectiveness of the Quad Helix (QH) appliance versus Rapid Maxillary Expanders (RME) in treating posterior cross-bite in Egyptian children during the mixed dentition stage. The study will also assess patient comfort and pain levels associated with each appliance.

Read the detailed description

The study involves 20 orthodontic patients aged 9-12 years with posterior cross-bite. Group A will receive the Quad Helix appliance, while Group B will receive Rapid Maxillary Expanders. Evaluation will be based on orthodontic study models, clinical photographs, and various radiographs including CBCT. Treatment will continue until complete correction is achieved, followed by a 3-month passive retention period.

Being tested
Quad Helix(QH) Appliance, Rapid Maxillary Expanders
Keywords
Quad Helix, Rapid Maxillary Expansion, Posterior cross-bite, Mixed Dentition, Egyptian children, Randomized clinical trials

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Quad Helix(QH) ApplianceDevice

    It is a fixed orthodontic appliance fabricated using stainless-steel wire and soldered to bands on upper first permanent molars.

  • Rapid Maxillary ExpandersDevice

    It is a fixed expansion device bonded on the upper first permanent molars and pre-molars. Activation is done at a rate of 0.25 mm twice daily (two turns per day)

Study groups in NCT07500194
Study groupRoleWhat they receive
Group A:Quad Helix ApplianceExperimentalParticipants in this group will receive treatment using a fixed Quad Helix (QH) appliance to correct posterior cross-bite. The appliance is fabricated using stainless steel wire and soldered to bands on the upper first permanent molars.
Receives: Device: Quad Helix(QH) Appliance
Group B: Rapid maxillary expandersActive comparatorParticipants in this group will receive treatment using fixed Rapid Maxillary Expanders (RME) bonded on the upper first permanent molars and pre-molars
Receives: Device: Rapid Maxillary Expanders

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Maxillary Arch Width Changes

    Measured on dental castes at the level of inter molar / inter canine width and Cone-beam computed tomography (CBCT) for upper arch

    Measured: Baseline and 6 months

Secondary outcomes (1)
  1. Treatment duration

    Measured: At the time of complete cross-bite correction (average of 6 months)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Mar 2026
  2. Study start30 Mar 2026 (estimated)
  3. Primary completion30 Dec 2027 (estimated)
  4. Study completion31 Mar 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
A randomized controlled clinical trial with two parallel groups. Patients are randomly assigned to either receive the Quad Helix appliance (Group A) or the Rapid Maxillary Expander (Group B)
Masking
None (open label)
Enrolment
20 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07500194
Sponsor's protocol ID
MG-ORTHO-2026
Acronym
Expansion
Status last verified
Mar 2026
First submitted
20 Mar 2026
Last updated
30 Mar 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: IPD will not be shared to maintain participant confidentiality and because the data is proprietary to the Orthodontic Department at Al-Azhar University.

Questions about this trial

What is this clinical trial studying?

A study testing Quad Helix(QH) Appliance and Rapid Maxillary Expanders in people with Posterior Crossbite and Maxillary Expansion, run by Al-Azhar University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 30 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Moustafa Galal Borham Moustafa Saad, Bachelor of dental Science (+201026896894 ext. +201155874709, moustafagalal.1.209@azhar.edu.eg), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Maxillary Arch Width Changes (time frame: Baseline and 6 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Mar 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in